1975
DOI: 10.1139/m75-186
|View full text |Cite
|
Sign up to set email alerts
|

A microplaque reduction assay for human and mouse interferon

Abstract: A microplaque reduction assay for human and mouse interferons is described, using plastic disposable multicompartmental plates with flat-bottomed wells of 6 mm in diameter. The procedure is rapid and reproducible and lends itself to a considerable degree of automation. Its potential application in other areas of virology, such as rapid screening of samples for virus content or assay of neutralizing antibodies, is also discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
49
0
2

Year Published

1980
1980
1990
1990

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 152 publications
(51 citation statements)
references
References 14 publications
0
49
0
2
Order By: Relevance
“…The construction of bacterial plasmids containing the various human leukocyte interferon genes and preparation of interferon extracts from bacterial cells have been described previously (Goeddel et al, 1980. The supernatants generated by this extraction procedure were collected and used in plaque reduction assays (Yelverton et al, 1981) or cytopathic effect inhibition assays (Campbell et al, 1975) using the National Institutes of Health leukocyte interferon standard G-023-901-527. These preparations of interferons derived from bacteria had specific activities in a range from 3.2 x 104 to 1.6 x 105 U/mg protein and extracts of bacterial cells containing plasmids lacking interferon gene sequences had no antiviral activity.…”
Section: Discussionmentioning
confidence: 99%
“…The construction of bacterial plasmids containing the various human leukocyte interferon genes and preparation of interferon extracts from bacterial cells have been described previously (Goeddel et al, 1980. The supernatants generated by this extraction procedure were collected and used in plaque reduction assays (Yelverton et al, 1981) or cytopathic effect inhibition assays (Campbell et al, 1975) using the National Institutes of Health leukocyte interferon standard G-023-901-527. These preparations of interferons derived from bacteria had specific activities in a range from 3.2 x 104 to 1.6 x 105 U/mg protein and extracts of bacterial cells containing plasmids lacking interferon gene sequences had no antiviral activity.…”
Section: Discussionmentioning
confidence: 99%
“…hIFN-a was induced by Newcastle disease virus infection ofhuman peripheral lymphocytes (5) as described (6). hIFN-a was assayed for antiviral activity by microplaque reduction with vesicular stomatitis virus as a challenge (7). One unit of interferon in our assay equals 1 unit of the National Institutes of Health reference interferons.…”
Section: Methodsmentioning
confidence: 99%
“…The production of IL-2 was measured by assaying the proliferative effects of culture supernatant fluids on a murine T-cell line (38). Blood mononuclear cells were stimulated with PHA-P for 24 Interferon activity of supernatant fluids obtained from PHA-Pstimulated blood lymphocytes was measured by using a viral plaque inhibition assay with human WISH cells (39). A standard amount of recombinant interferon a A/D (Hoffman LaRoche, Nutley, NJ) was used as a positive control.…”
Section: Imentioning
confidence: 99%